nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Betamethasone—PLA2G1B—atherosclerosis	0.00995	0.376	CrCbGaD
Amcinonide—Dexamethasone—PLA2G1B—atherosclerosis	0.00579	0.219	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—CX3CR1—atherosclerosis	0.00426	0.00437	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CASR—atherosclerosis	0.00426	0.00437	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CX3CL1—atherosclerosis	0.00418	0.00429	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.00414	0.00425	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.00406	0.00417	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00404	0.00415	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00404	0.00415	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.00398	0.00408	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CNR2—atherosclerosis	0.00396	0.00407	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00394	0.00405	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00394	0.00404	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.00393	0.00404	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HRH1—atherosclerosis	0.0039	0.004	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.00386	0.00397	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.00386	0.00397	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IFNG—atherosclerosis	0.0037	0.0038	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00366	0.00376	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AGT—atherosclerosis	0.00365	0.00375	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CCL5—atherosclerosis	0.00364	0.00374	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AGT—atherosclerosis	0.00361	0.00371	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.0036	0.0037	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.00356	0.00366	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—atherosclerosis	0.00354	0.00364	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRH1—atherosclerosis	0.00354	0.00363	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.00353	0.00362	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00346	0.00355	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00344	0.00353	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—atherosclerosis	0.00344	0.00353	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—AHR—atherosclerosis	0.00341	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL3—atherosclerosis	0.0034	0.0035	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.00339	0.00349	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—F2—atherosclerosis	0.00338	0.00347	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00337	0.00346	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.00336	0.00345	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—F2—atherosclerosis	0.00333	0.00342	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—atherosclerosis	0.0033	0.00339	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—atherosclerosis	0.00328	0.124	CrCbGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00327	0.00336	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.00324	0.00333	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.00317	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—atherosclerosis	0.00311	0.00319	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCR2—atherosclerosis	0.00308	0.00316	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDNRA—atherosclerosis	0.00308	0.00316	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.00308	0.00316	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00305	0.00314	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.00305	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—AGT—atherosclerosis	0.00304	0.00313	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.00303	0.00311	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.00302	0.0031	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.00302	0.0031	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GHRL—atherosclerosis	0.003	0.00308	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.00298	0.00306	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CCL2—atherosclerosis	0.00297	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00291	0.00299	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.00291	0.00299	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.0029	0.00298	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00289	0.00297	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.00282	0.0029	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00279	0.00286	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00269	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK3—atherosclerosis	0.00264	0.00271	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—KNG1—atherosclerosis	0.00263	0.00271	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGTR1—atherosclerosis	0.00262	0.00269	CbGpPWpGaD
Amcinonide—Dexamethasone—NOS2—atherosclerosis	0.00258	0.0978	CrCbGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.00257	0.00264	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—atherosclerosis	0.00256	0.00263	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL4—atherosclerosis	0.00256	0.00263	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.00253	0.0026	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.00253	0.00259	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—UTS2—atherosclerosis	0.00251	0.00258	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00244	0.0025	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00242	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.00241	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CASR—atherosclerosis	0.00241	0.00247	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—atherosclerosis	0.00239	0.00246	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00237	0.00243	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.00236	0.00243	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.00235	0.00241	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.00234	0.0024	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	0.00229	0.00235	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—UTS2—atherosclerosis	0.00228	0.00234	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.00226	0.00232	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR2—atherosclerosis	0.00224	0.0023	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00224	0.0023	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDN1—atherosclerosis	0.00222	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL5—atherosclerosis	0.0022	0.00226	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CX3CR1—atherosclerosis	0.00219	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CASR—atherosclerosis	0.00219	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CX3CL1—atherosclerosis	0.00214	0.0022	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.00211	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.00209	0.00215	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRH1—atherosclerosis	0.00209	0.00215	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.00209	0.00214	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00206	0.00211	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.00206	0.00211	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.00205	0.00211	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR2—atherosclerosis	0.00203	0.00209	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.00203	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00199	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—atherosclerosis	0.00198	0.00204	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—atherosclerosis	0.00193	0.00198	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.0019	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGT—atherosclerosis	0.00184	0.00189	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.00181	0.00186	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LPL—atherosclerosis	0.00181	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.0018	0.00185	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.00177	0.00182	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL3—atherosclerosis	0.00175	0.00179	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.00174	0.00179	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCR2—atherosclerosis	0.00174	0.00179	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDNRA—atherosclerosis	0.00174	0.00179	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.00173	0.00178	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—F2—atherosclerosis	0.0017	0.00175	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GHRL—atherosclerosis	0.0017	0.00174	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.00165	0.00169	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA4—atherosclerosis	0.00164	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00163	0.00168	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.00163	0.00167	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.00159	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00159	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCR2—atherosclerosis	0.00158	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDNRA—atherosclerosis	0.00158	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00158	0.00162	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.00156	0.00161	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—atherosclerosis	0.00156	0.0589	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—AGT—atherosclerosis	0.00154	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GHRL—atherosclerosis	0.00154	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCL2—atherosclerosis	0.00152	0.00156	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LEP—atherosclerosis	0.00151	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL4—atherosclerosis	0.00151	0.00155	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.00149	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—KNG1—atherosclerosis	0.00149	0.00153	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR1—atherosclerosis	0.00148	0.00152	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	0.00146	0.0015	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.00145	0.00149	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA2—atherosclerosis	0.00141	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KNG1—atherosclerosis	0.00135	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—UTS2—atherosclerosis	0.00135	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR1—atherosclerosis	0.00134	0.00138	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.00132	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.0013	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—INS—atherosclerosis	0.00129	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CX3CR1—atherosclerosis	0.00129	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASR—atherosclerosis	0.00129	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.00128	0.00131	CbGpPWpGaD
Amcinonide—Betamethasone—PTGS2—atherosclerosis	0.00128	0.0482	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—CX3CL1—atherosclerosis	0.00127	0.0013	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.00126	0.00129	CbGpPWpGaD
Amcinonide—Prednisone—ALB—atherosclerosis	0.00126	0.0476	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDN1—atherosclerosis	0.00125	0.00129	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.00125	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCL5—atherosclerosis	0.00124	0.00128	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.00124	0.00127	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.00123	0.00126	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.00121	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR2—atherosclerosis	0.0012	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—atherosclerosis	0.0012	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MMP3—atherosclerosis	0.0012	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.0012	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.00119	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00118	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDN1—atherosclerosis	0.00114	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL5—atherosclerosis	0.00113	0.00116	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.00112	0.00115	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCG—atherosclerosis	0.00107	0.0011	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VWF—atherosclerosis	0.00107	0.0011	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOC3—atherosclerosis	0.00106	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LDLR—atherosclerosis	0.00106	0.00109	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGT—atherosclerosis	0.00104	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL3—atherosclerosis	0.00103	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NCF1—atherosclerosis	0.000989	0.00102	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—F2—atherosclerosis	0.000962	0.000988	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGT—atherosclerosis	0.000946	0.000971	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDNRA—atherosclerosis	0.000934	0.000959	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCR2—atherosclerosis	0.000934	0.000959	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CYBA—atherosclerosis	0.000929	0.000955	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000927	0.000952	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000921	0.000946	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000918	0.000943	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLAT—atherosclerosis	0.00091	0.000934	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PARP1—atherosclerosis	0.00091	0.000934	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GHRL—atherosclerosis	0.00091	0.000934	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—F2—atherosclerosis	0.000874	0.000897	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.00087	0.000893	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000869	0.000893	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000836	0.000859	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000834	0.000856	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000817	0.000839	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000809	0.000831	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KNG1—atherosclerosis	0.000799	0.00082	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR1—atherosclerosis	0.000794	0.000815	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCL2—atherosclerosis	0.000779	0.0008	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000778	0.000799	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLG—atherosclerosis	0.000774	0.000795	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000761	0.000781	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000753	0.000774	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.00075	0.00077	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—atherosclerosis	0.000742	0.0281	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—SOCS3—atherosclerosis	0.000733	0.000752	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP3—atherosclerosis	0.000707	0.000727	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000706	0.000725	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF2—atherosclerosis	0.000704	0.000723	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—atherosclerosis	0.0007	0.000719	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOB—atherosclerosis	0.000684	0.000702	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000678	0.000696	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDN1—atherosclerosis	0.000673	0.000691	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL5—atherosclerosis	0.000668	0.000686	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LPL—atherosclerosis	0.000653	0.000671	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCG—atherosclerosis	0.000635	0.000652	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SPP1—atherosclerosis	0.000618	0.000635	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—atherosclerosis	0.000616	0.000632	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000605	0.000621	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000582	0.000598	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFB—atherosclerosis	0.000572	0.000588	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000565	0.00058	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGT—atherosclerosis	0.000559	0.000574	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LEP—atherosclerosis	0.000547	0.000562	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—atherosclerosis	0.000547	0.000562	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—atherosclerosis	0.000542	0.000557	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—atherosclerosis	0.000541	0.000556	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.000528	0.000542	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—atherosclerosis	0.000523	0.000537	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—F2—atherosclerosis	0.000516	0.00053	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1B—atherosclerosis	0.000496	0.00051	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—atherosclerosis	0.000494	0.000507	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000488	0.000501	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	0.000481	0.000494	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—atherosclerosis	0.000473	0.000486	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—INS—atherosclerosis	0.000468	0.00048	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCL2—atherosclerosis	0.00046	0.000472	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1—atherosclerosis	0.000452	0.000465	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PARP1—atherosclerosis	0.000442	0.000454	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	0.000434	0.000445	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—atherosclerosis	0.000429	0.000441	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR2—atherosclerosis	0.000419	0.00043	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—atherosclerosis	0.00041	0.000421	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—atherosclerosis	0.000364	0.000374	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—atherosclerosis	0.000351	0.000361	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—atherosclerosis	0.000346	0.000355	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SIRT1—atherosclerosis	0.000337	0.000346	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—atherosclerosis	0.000329	0.000338	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NFKB1—atherosclerosis	0.000325	0.000334	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK8—atherosclerosis	0.00032	0.000329	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—atherosclerosis	0.000319	0.000328	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—atherosclerosis	0.000295	0.000303	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—atherosclerosis	0.000292	0.0003	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARA—atherosclerosis	0.00028	0.000288	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—atherosclerosis	0.000279	0.000287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—atherosclerosis	0.000271	0.000278	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—atherosclerosis	0.000254	0.000261	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—atherosclerosis	0.000232	0.000238	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—atherosclerosis	0.000209	0.000214	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—atherosclerosis	0.000204	0.00021	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—atherosclerosis	0.000188	0.000194	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—atherosclerosis	0.000136	0.00014	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—atherosclerosis	9.16e-05	9.41e-05	CbGpPWpGaD
